Table 1.
Patient Baseline Characteristics (n=19)
| Characteristic | Value |
|---|---|
| Median age, y (range) | 67y (45–74y) |
| Age, (N, %) | |
| ≤ 49 | 1 (5%) |
| 50–69 | 13 (68%) |
| ≥ 70 | 5 (26%) |
| Sex, (N, %) | |
| Male | 6 (32%) |
| Female | 13 (68%) |
| Race, (N, %) | |
| White | 18 (95%) |
| Black | 0 |
| Hispanic | 0 |
| Asian | 1 (5%) |
| Other | 0 |
| ECOG Performance Status | |
| 0 | 7 (37%) |
| 1 | 12 (63%) |
| Type of Cholangiocarcinoma | |
| Intrahepatic | 16 (84%) |
| Extrahepatic | 3 (16%) |
| Presentation | |
| Primary Metastatic | 15 (79%) |
| Recurrent Metastatic | 4 (21%) |
| Locally Advanced | 0 |
| Histology | |
| Well differentiated | 0 |
| Moderately differentiated | 10 (53%) |
| Poorly differentiated | 7 (37%) |
| AJCC Stage, (N, %) | |
| III | 0 |
| IV | 19 (100%) |
| Prior Local Therapy | |
| Surgery | 4 (21%) |
| Chemoembolization | 4 (21%) |
| Radioembolization | 2 (11%) |
| Liver Radiation | 0 |
| Prior Systemic Therapy | |
| 1 line of chemotherapy | 11 (58%) |
| 2 lines of chemotherapy | 8 (42%) |